Literature DB >> 20801190

Protein profiling of Guillain-Barrè syndrome cerebrospinal fluid by two-dimensional electrophoresis and mass spectrometry.

Simona D'Aguanno1, Diego Franciotta, Santina Lupisella, Alessandra Barassi, Damiana Pieragostino, Alessandra Lugaresi, Diego Centonze, Gianlodovico Melzi D'Eril, Sergio Bernardini, Giorgio Federici, Andrea Urbani.   

Abstract

Protein profiling of cerebrospinal fluid in Guillain-Barrè syndrome (GBS), an acute and immune-mediated disease affecting the peripheral nervous system, was performed by two-dimensional electrophoresis. Significant modulated spots in GBS patients vs. control groups (a group of multiple sclerosis patients and one of healthy donors) underwent MALDI-TOF/TOF investigation. Inflammation-related proteins, such as vitamin D-binding protein, beta-2 glycoprotein I (ApoH), and a complement component C3 isoform were up-regulated in GBS, whereas transthyretin (the monomer and the dimer forms), apolipoprotein E, albumin and five of its fragments were down-regulated. Then, we used an isoelectric-focusing-dinitrophenylhydrazine-based technique to analyse the extent of carbonylation and, as a result, of oxidative damage of GBS CSF proteome. We observed a major sensitivity to carbonylation for albumin and alpha-glycoprotein in inflammation and a selective increase of reactivity for a glycosylated Fab from an IgM globulin in GBS CSF. Our results add new proteins to candidate CSF features of GBS, and suggest that oxidative stress could contribute to the immunopathological mechanisms in this syndrome.
Copyright © 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20801190     DOI: 10.1016/j.neulet.2010.08.060

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  9 in total

1.  Age-related oxidative modifications of transthyretin modulate its amyloidogenicity.

Authors:  Lei Zhao; Joel N Buxbaum; Natàlia Reixach
Journal:  Biochemistry       Date:  2013-03-04       Impact factor: 3.162

2.  Cerebrospinal fluid biomarkers of neuropathologically diagnosed Parkinson's disease subjects.

Authors:  Chera L Maarouf; Thomas G Beach; Charles H Adler; Holly A Shill; Marwan N Sabbagh; Terence Wu; Douglas G Walker; Tyler A Kokjohn; Alex E Roher
Journal:  Neurol Res       Date:  2012-09       Impact factor: 2.448

3.  The Pathogenesis of the Demyelinating Form of Guillain-Barre Syndrome (GBS): Proteo-peptidomic and Immunological Profiling of Physiological Fluids.

Authors:  Rustam H Ziganshin; Olga M Ivanova; Yakov A Lomakin; Alexey A Belogurov; Sergey I Kovalchuk; Igor V Azarkin; Georgij P Arapidi; Nikolay A Anikanov; Victoria O Shender; Mikhail A Piradov; Natalia A Suponeva; Anna A Vorobyeva; Alexander G Gabibov; Vadim T Ivanov; Vadim M Govorun
Journal:  Mol Cell Proteomics       Date:  2016-05-03       Impact factor: 5.911

4.  Identification of gene networks and pathways associated with Guillain-Barré syndrome.

Authors:  Kuo-Hsuan Chang; Tzi-Jung Chuang; Rong-Kuo Lyu; Long-Sun Ro; Yih-Ru Wu; Hong-Shiu Chang; Chin-Chang Huang; Hung-Chou Kuo; Wen-Chuin Hsu; Chun-Che Chu; Chiung-Mei Chen
Journal:  PLoS One       Date:  2012-01-10       Impact factor: 3.240

5.  Quantitative proteomics reveals Piccolo as a candidate serological correlate of recovery from Guillain-Barré syndrome.

Authors:  Lourdes Mateos-Hernández; Margarita Villar; Ernesto Doncel-Pérez; Marco Trevisan-Herraz; Ángel García-Forcada; Francisco Romero Ganuza; Jesús Vázquez; José de la Fuente
Journal:  Oncotarget       Date:  2016-11-15

6.  Heme Oxygenase 1 in Schwann Cells Regulates Peripheral Nerve Degeneration Against Oxidative Stress.

Authors:  Muwoong Kim; Hyosun Kim; Dogyeong Kim; Dokyoung Kim; Youngbuhm Huh; Chan Park; Hyung-Joo Chung; Junyang Jung; Na Young Jeong
Journal:  ASN Neuro       Date:  2019 Jan-Dec       Impact factor: 4.146

Review 7.  Biomarkers of Guillain-Barré Syndrome: Some Recent Progress, More Still to Be Explored.

Authors:  Ying Wang; Shuang Sun; Jie Zhu; Li Cui; Hong-Liang Zhang
Journal:  Mediators Inflamm       Date:  2015-09-16       Impact factor: 4.711

Review 8.  Albumin and multiple sclerosis.

Authors:  Steven M LeVine
Journal:  BMC Neurol       Date:  2016-04-12       Impact factor: 2.474

Review 9.  Could Proteomics Become a Future Useful Tool to Shed Light on the Mechanisms of Rare Neurodegenerative Disorders?

Authors:  Maddalena Cagnone; Anna Bardoni; Paolo Iadarola; Simona Viglio
Journal:  High Throughput       Date:  2018-01-10
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.